FDA to Decrease Insulin Certification Program Fees

Summary

The Food and Drug Administration (FDA) is issuing an interim final rule to adjust the fee schedule for the insulin certification program, citing the need to accurately reflect the agency's actual costs, following experience that the current fees do not accurately reflect these costs.